EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSDARG00000013236
Gene Symbol: DHCR24
6 Enzyme and pathways 5 Cross references
209 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase A

Ensembl ID : ENSDARG00000052734
Gene Symbol: HMGCRA
4 Enzyme and pathways 5 Cross references
154 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase B

Ensembl ID : ENSDARG00000105206
Gene Symbol: HMGCRB
5 Cross references
206 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1a

Ensembl ID : ENSDARG00000062304
Gene Symbol: PDPK1A
5 Cross references
172 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1b

Ensembl ID : ENSDARG00000018285
Gene Symbol: PDPK1B
55 Enzyme and pathways 5 Cross references
222 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase B

Ensembl ID : ENSDARG00000044935
Gene Symbol: HPDB
4 Enzyme and pathways 5 Cross references
207 Possible Orthologues:

5'-Nucleotidase, Ecto (Cd73)

Ensembl ID : ENSDARG00000071017
Gene Symbol: NT5E
8 Enzyme and pathways 5 Cross references
206 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1a A

Ensembl ID : ENSDARG00000093745
Gene Symbol: HTR1AA
8 Enzyme and pathways 5 Cross references
497 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1a B

Ensembl ID : ENSDARG00000057098
Gene Symbol: HTR1AB
5 Cross references
138 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1b

Ensembl ID : ENSDARG00000053987
Gene Symbol: HTR1B
8 Enzyme and pathways 5 Cross references
56 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1d, G Protein-Coupled

Ensembl ID : ENSDARG00000054124
Gene Symbol: HTR1D
8 Enzyme and pathways 5 Cross references
54 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2a, Genome Duplicate A

Ensembl ID : ENSDARG00000057029
Gene Symbol: HTR2AA
8 Enzyme and pathways 4 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).